CPDD Ongoing Updates and Resources
Related to 2025 Executive OrdersCPDD Ongoing Updates and Resources
Related to 2025 Executive OrdersTHE LATEST NEWS AND STATEMENTS
Download CPDD’s New Informational Flyers
These new handouts provide a comprehensive overview of current efforts and policy priorities aimed at supporting addiction science and research. The materials highlight the importance of sustained funding for the National Institute on Drug Abuse (NIDA), emphasizing its role in advancing evidence-based approaches to substance use prevention, treatment, and recovery. The flyers include key statistics, legislative updates, and calls to action for stakeholders to engage with policymakers. They...
CPDD Advances National Advocacy for Addiction Research and Policy Reform
Over the past several months,CPDD Public Policy Committee has been at the forefront of national advocacy efforts to advance research in substance use disorders. These initiatives have focused on increasing federal funding, streamlining research regulations, and preparing for shifting political landscapes following the 2024 elections.
CPDD’s Response to NIH Indirect Cost Rate Changes & How You Can Help
CPDD is aware of the Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates, released late Friday night. We are actively reviewing its implications to assess the impact on NIH-funded research, universities, and the broader scientific community. We recognize the urgency of this issue and the significant consequences of the indirect cost rate cap, particularly in sustaining research institutions, driving innovation, and advancing science. CPDD remains committed...
CPDD Community Update: Addressing NIH Program Changes and Ongoing Support
CPDD Community Update: Addressing NIH Program Changes and Ongoing Support We understand that the recent announcement regarding the halt of NIH programs, external communications, and travel restrictions has created a great deal of concern and uncertainty within the CPDD community. These changes are likely to impact not only ongoing projects but also future planning and collaborations. We want to acknowledge the challenges that many of our colleagues, researchers, and partners are currently...
EXECUTIVE ORDERS, LEGISLATIVE RESOURCES AND GOVENMENT MEMOS
SEARCHABLE OPM MEMOS DATABASE
CONSISTENTLY UPDATED
12.18.2025 INCREASING MEDICAL MARIJUANA AND CANNABIDIOL RESEARCH
12.15.25 DESIGNATING FENTANYL AS A WEAPON OF MASS DESTRUCTION
8.8.25 IMPROVING OVERSIGHT OF FEDERAL GRANTMAKING
How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals?
FDA-NIH Workshop Reducing Animal Testing
7.9.2025
NIH RESCINDS, AT LEAST FOR NOW, ITS DEI BAN ON GRANTS TO INSTITUTIONS 06.10.2025
THE BETHESDA DECLARATION: A CALL FOR NIH AND HHS LEADERSHIP TO DELIVER ON PROMISES OF ACADEMIC FREEDOM AND SCIENTIFIC EXCELLENCE 06.10.2025
HELP Committee Minority Report 05.13.2025
SCIENTISTS ARE PUSHING TO GET THEIR GRANTS REINSTATED - AND SOME ARE WINNING ARTICLE
05.20.2025
LETTER ON DISCRETIONARY FUNDING LEVELS FOR FY26
05.02.2025
PRESIDENT TRUMP'S FY26 DISCRETIONARY FUNDING REQUEST
ADDICTION SCIENCE DEFENSE NETWORK STATEMENT OF CONCERN
SENATE CONGRESSIONAL FORUM HIGHLIGHT VIDEO
03.26.2025
HHS REORGANIZATION MEMO
03.27.2025
INDIRECT COST LOSS BY CONGRESSIONAL DISTRICT
03.17.2025
REFORMING THE NATIONAL INSTITUTES OF HEALTH FRAMEWORK FOR DISCUSSION
03.06.2025
NIH CENTRALIZES PEER REVIEW TO IMPROVE EFFICIENCY AND STRENGTHEN INTEGRITY
03.06.2025
INDIRECT COST RATE PPRELIMINARY INJUNCTION GRANTED
03.05.2025
2025 APPROPRIATIONS BILL
03.05.2025
SPARE ACT
SCIENTISTS WARN OF LONG-TERM DAMAGE AS TRUMP'S ORDERS SLOW RESEARCH
RFK JR. ROLLS BACK TRANSPARENCY POLICY ON MEDICAID AND NIH CHANGES
RFK JR. MOVES TO ELIMINATE PUBLIC COMMENT ON HHS DECISIONS
ASSOCIATION OF AMERICAN UNIVERSITIES BREAKING DOWN THE COSTS OF FEDERAL RESEARCH AT UNIVERSITIES
EXPLANATION OF INDIRECTS
IMAGE
FAQ ABOUT FACILITIES AND ADMINISTRATIVE (F&A) COSTS OF FEDERALLY SPONSORED RESEARCH
02.10.2025
UMR: NIH ROLE IN SUSTAINING THE US ECONOMY
2024 UPDATE
IMPLEMENTING THE PRESIDENT'S "DEPARTMENT OF GOVERNMENT EFFECIENCY" WORKFORCE OPTIMIZATION INITIATIVE
02.11.2025
RESTRAINING ORDER TO IDC CUTS TO THE EDUCATIONAL COMMUNITY
02.11.2025
COURT ORDER TO RESTORE PUBLIC HEALTH WEBSITES (CDC, FDA, ETC.)
02.11.2025
NIH INDIRECT COST RATE IMPACT BY STATE
02.09.2025
AAMC COURT FILING
02.07.2025
NOTICE OF TEMPORARY RESTRAINING ORDER IN NEW YORK ET AL. V. TRUMP
01.31.2025
RESCISSION OF TEMPORARY PAUSE OF AGENCY GRANT, LOAN, AND OTHER FINANCIAL ASSISTANCE PROGRAMS MEMO
01.29.2025
TEMPORARY INJUNCTION TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
COURT FILING TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
SUPPLEMENTAL GUIDANCE TO THE 2024 NIH GRANT POLICY STATEMENT: INDIRECT COST RATES
02.07.2025
NATIONAL SCIENCE COUNCIL IMPLEMENTATION OF RECENT EXECUTIVE ORDERS
01.29.2025
DEFERRED RESIGNATION EMAIL TO FEDERAL EMPLOYEES
01.28.2025
FRIENDS OF NIDA - INDIRECT COSTS SIGN ON LETTER
02.21.2025
OTHER ORGANIZATIONAL RESOURCES AND LETTERS
JAMA COMMENTARY ON FIRST 100 DAYS & CHANGES TO ADDICTION POLICY
How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals? 7.18.25